INCY vs MEDP
Incyte vs Medpace — AI-powered side-by-side comparison
| Metric | INCY | MEDP |
|---|
| AI Score |
71
|
67
|
| Price |
$120.61
|
$590.35
|
| P/E Ratio |
14.83×
|
33.97×
|
| ROE |
24.9%
|
98.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
92.6%
|
28.8%
|
| Debt / Equity |
0.01×
|
0.28×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
53.3
|
64.4
|
| Beta |
0.758
|
1.151
|
| Expected Upside |
—
|
+5.5%
|
AI Committee View
Current Innellis committee reasoning for INCY versus MEDP.
INCY leads by 4 points.
INCY scores 71/100 (Buy) versus MEDP at 67/100 (Buy).
INCY Committee View
100% agreement
5 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 4 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
MEDP Committee View
80% agreement
5 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is bollinger bandwidth of 19.8% signals elevated volatility. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Bollinger bandwidth of 19.8% signals elevated volatility — Risk